Single User License
INR 100335
Site License
INR 200670
Corporate User License
INR 301005

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Advenchen Laboratories, LLC-Product Pipeline Review-2015

Advenchen Laboratories, LLC-Product Pipeline Review-2015

  Request for Sample Report

Executive Summary

Advenchen Laboratories, LLC-Product Pipeline Review-2015


Global Markets Direct's, 'Advenchen Laboratories, LLC-Product Pipeline Review-2015', provides an overview of the Advenchen Laboratories, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advenchen Laboratories, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Advenchen Laboratories, LLC including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Advenchen Laboratories, LLC's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Advenchen Laboratories, LLC's pipeline products

Reasons To Buy

Evaluate Advenchen Laboratories, LLC's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Advenchen Laboratories, LLC in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Advenchen Laboratories, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Advenchen Laboratories, LLC and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advenchen Laboratories, LLC

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Advenchen Laboratories, LLC and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Advenchen Laboratories, LLC Snapshot 5

Advenchen Laboratories, LLC Overview 5

Key Information 5

Key Facts 5

Advenchen Laboratories, LLC-Research and Development Overview 6

Key Therapeutic Areas 6

Advenchen Laboratories, LLC-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Advenchen Laboratories, LLC-Pipeline Products Glance 11

Advenchen Laboratories, LLC-Late Stage Pipeline Products 11

Phase III Products/Combination Treatment Modalities 11

Advenchen Laboratories, LLC-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Advenchen Laboratories, LLC-Early Stage Pipeline Products 14

IND/CTA Filed Products/Combination Treatment Modalities 14

Preclinical Products/Combination Treatment Modalities 15

Advenchen Laboratories, LLC-Drug Profiles 16

apatinib 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

AL-3818 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

lucitanib 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

AL-6802 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

AL-2846 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

AL-8326 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

AL-58203 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

AL-58805 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Advenchen Laboratories, LLC-Pipeline Analysis 28

Advenchen Laboratories, LLC-Pipeline Products by Target 28

Advenchen Laboratories, LLC-Pipeline Products by Route of Administration 30

Advenchen Laboratories, LLC-Pipeline Products by Molecule Type 31

Advenchen Laboratories, LLC-Pipeline Products by Mechanism of Action 32

Advenchen Laboratories, LLC-Recent Pipeline Updates 34

Advenchen Laboratories, LLC-Dormant Projects 36

Advenchen Laboratories, LLC-Locations And Subsidiaries 37

Head Office 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

List of Tables

Advenchen Laboratories, LLC, Key Information 5

Advenchen Laboratories, LLC, Key Facts 5

Advenchen Laboratories, LLC-Pipeline by Indication, 2015 7

Advenchen Laboratories, LLC-Pipeline by Stage of Development, 2015 9

Advenchen Laboratories, LLC-Monotherapy Products in Pipeline, 2015 10

Advenchen Laboratories, LLC-Phase III, 2015 11

Advenchen Laboratories, LLC-Phase II, 2015 12

Advenchen Laboratories, LLC-Phase I, 2015 13

Advenchen Laboratories, LLC-IND/CTA Filed, 2015 14

Advenchen Laboratories, LLC-Preclinical, 2015 15

Advenchen Laboratories, LLC-Pipeline by Target, 2015 28

Advenchen Laboratories, LLC-Pipeline by Route of Administration, 2015 30

Advenchen Laboratories, LLC-Pipeline by Molecule Type, 2015 31

Advenchen Laboratories, LLC-Pipeline Products by Mechanism of Action, 2015 33

Advenchen Laboratories, LLC-Recent Pipeline Updates, 2015 34

Advenchen Laboratories, LLC-Dormant Developmental Projects,2015 36

List of Figures

Advenchen Laboratories, LLC-Pipeline by Top 10 Indication, 2015 7

Advenchen Laboratories, LLC-Pipeline by Stage of Development, 2015 9

Advenchen Laboratories, LLC-Monotherapy Products in Pipeline, 2015 10

Advenchen Laboratories, LLC-Pipeline by Top 10 Target, 2015 28

Advenchen Laboratories, LLC-Pipeline by Top 10 Route of Administration, 2015 30

Advenchen Laboratories, LLC-Pipeline by Top 10 Molecule Type, 2015 31

Advenchen Laboratories, LLC-Pipeline Products by Top 10 Mechanism of Action, 2015 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Advenchen Laboratories, LLC; Advenchen Laboratories, LLC - Key Therapeutics; Advenchen Laboratories, LLC - Pipeline Overview and Promising Molecules; Advenchen Laboratories, LLC - News; Advenchen Laboratories, LLC - Latest Updates; Advenchen Laboratories, LLC - Pipeline; Advenchen Laboratories, LLC - Discontinued/Dormant Projects

Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]